COVID-19 screening of asymptomatic people could decrease infections, deaths

COVID-19 screening of asymptomatic people could decrease infections, deaths
New research suggests when the COVID-19 pandemic is slowing, low-cost, recurring screening of asymptomatic people—at an expense of approximately $3 or less per test every two weeks—could decrease COVID-19 infections and deaths and be cost-effective. When the pandemic is surging, screening can be cost-effective when done more often, even if tests costs are higher. The report—led by researchers at Massachusetts General Hospital (MGH) - was recently published in Clinical Infectious Diseases.